Correlation between maternal inflammatory markers and fetomaternal adiposity

Cytokine

Volumn 60, Issue 1, 2012, Pages 96-99

  Farah, Nadine ^a   Hogan, Andrew E ^b   O'Connor, Norah ^a   Kennelly, Mairead M ^a   O'Shea, Donal ^b   Turner, Michael J ^a  

^a UNIVERSITY COLLEGE DUBLIN   (Ireland)

^b ST VINCENT S UNIVERSITY HOSPITAL   (Ireland)

Author keywords

Birthweight; Cytokines; Fetal body composition; Interleukin; Maternal body composition

Indexed keywords

CYTOKINE; INTERLEUKIN 6; INTERLEUKIN 8; INTERLEUKIN BETA; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BIOELECTRICAL IMPEDANCE; BIRTH WEIGHT; BODY COMPOSITION; BODY MASS; COHORT ANALYSIS; FEMALE; FETUS ECHOGRAPHY; HUMAN; IMPEDANCE; INFLAMMATION; MATERNAL AGE; NORMAL HUMAN; OBESITY; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL; PROSPECTIVE STUDY; THIRD TRIMESTER PREGNANCY;

ADIPOSITY; ADULT; BIOLOGICAL MARKERS; BODY MASS INDEX; COHORT STUDIES; CYTOKINES; FEMALE; FETAL WEIGHT; GESTATIONAL AGE; HUMANS; INFLAMMATION MEDIATORS; INTERLEUKIN-6; INTERLEUKIN-8; MATERNAL AGE; PREGNANCY; PREGNANCY TRIMESTER, THIRD; ULTRASONOGRAPHY, PRENATAL; YOUNG ADULT;

EID: 84865406188     PISSN: 10434666     EISSN: 10960023     Source Type: Journal    
DOI: 10.1016/j.cyto.2012.05.024     Document Type: Article

References (34)

1. Barry S., Fattah C., Farah N., Broderick V., Stuart B., Turner M.J. The growing challenge of maternal obesity. IMJ 2009, 102:5-6.
2. Heselhurst N., Simpson H., Ells L.J., Rankin J., Wilkinson J., Lang R., et al. The impact of maternal BMI status on pregnancy outcomes with immediate short-term obstetric resource implications: a meta-analysis. Obes Rev 2008, 9:635-683.
3. Farah N., Maher N., Barry S., Kennelly M., Stuart B., Turner M.J. Maternal morbid obesity and obstetric outcomes. Obes Facts 2009, 2:352-354.
4. Guerre-Millo M. Adipose tissue and cytokines: for better or worse. Diabetes Metab 2004, 30:9-13.
5. Browning L.M., Krebs J.D., Magee E.C., Fruhnbeck G., Jebb S.A. Circulating markers of inflammation and their link to indices of adiposity. Obes Facts 2008, 1:259-265.
6. Maachi M., Pieroni L., Bruckert E., Jardel C., Fellahi S., Hainque B., et al. Systemic low-grade inflammation is related to circulating and adipose tissue TNF-α, leptin and IL-6 in obese women. Int J Obes Rel Metab Disord 2004, 28:993-997.
7. Ramsay J.E., Ferrell W.R., Crawford L., Wallace M., Greer I.A., Sattar N. Maternal obesity is associated with dysregulation of metabolic, vascular, and inflammatory pathways. J Clin Endocrinol Metab 2002, 87:4231-4237.
8. Richardson A.C., Carpenter M.W. Inflammatory mediators in gestational diabetes mellitus. Obstet Gynecol Clin N Am 2007, 34:213-224.
9. Walker J.J. Inflammation and preeclampsia. Preg Hyper 2011, 1:43-47.
10. Radaelli T., Varastehpour A., Catalano P., Hauguel-de Mouzon S. Gestational diabetes induces placental genes for chronic stress and inflammatory pathways. Diabetes 2003, 52:2951-2958.
11. Coughlin M.T., Oliva K., Georgiou H.M., Permezel J.M., Rice G.E. Glucose-induced release of tumour necrosis factor- alpha from human placental and adipose tissues in gestational diabetes mellitus. Diabetes Med 2001, 18:921-927.
12. Catalano P.M., Ehrenberg H.M. The short- and long term implications of maternal obesity on the mother and her offspring. BJOG 2006, 113:1126-1133.
13. Villar J., Carroli G., Wojdyla D., Abalos E., Giordano D., Ba'aqueel H., et al. Preeclampsia, gestational hypertension and intrauterine growth restriction, related or independent conditions?. AJOG 2006, 194:921-931.
14. Lau D.C.W. The molecular biology of obesity. Obesity and pregnancy 2008, Royal Society of Medicine Press. M. Rees, M. Karoshi, L. Keith (Eds.).
15. Farah N., Stuart B., Donnelly V., Kennelly M., Turner M.J. Influence of maternal body composition on birth weight. Eur J Obstet Gynecol Reprod Biol 2011, 157:7-14.
16. Gardeil F., Greene R., Stuart B., Turner M.J. Subcutaneous fat in the fetal abdomen as a predictor of growth restriction. Obstet Gynecol 1999, 94:209-212.
17. Yudkin J.S., Stehouwer C.D.A., Emeis J.J., Coppack S.W. C-reactive protein in healthy subjects associations with obesity, insulin resistance, and endothelial dysfunction. Arterioscler Thromb Vasc Biol 1999, 19:972-978.
18. Ford E.S. Body mass index, diabetes and C-reactive protein among U.S. adults. Diabetes Care 1999, 22:1971-1977.
19. Visser M., Bouter L.M., McQuillan G.M., Wener M.H., Harris T.B. Elevated C-reactive protein levels in overweight and obese adults. JAMA 1999, 282:2131-2135.
20. Greenberg A.S., Obin M.S. Obesity and the role of adipose tissue in inflammation and metabolism. Am J Clin Nutr 2006, 83:461S-465S.
21. Canoz M., Erdenen F., Uzun H., Muderrisoglu A., Aydin S. The relationship of inflammatory cytokines with asthma and obesity. Clin Invest Med 2008, 3:E373.
22. Madan J.C., Davis J.M., Craig W.Y., Collins M., Allan W., Quinn R., et al. Maternal obesity and markers of inflammation in pregnancy. Cytokine 2009, 47:61-64.
23. Catalano P.M., Presley L., Minium J., Hauguel-De Mouzon S. Fetuses of obese mothers develop insulin resistance in utero. Diabetes Care 2009, 32:1076-1080.
24. Kirwan J.P., Hauguel-De Mouzon S., Lepercq J., Chalier J.C., Huston-Presley L., Friedman J., et al. TNF-α is a predictor of insulin resistance in human pregnancy. Diabetes 2002, 51:2207-2213.
25. Chen H., Yang Y., Hu X., Yelavarthi K., Fishback J., Hunt J. Tumour necrosis factor alpha mRNA and protein are present in human placental and uterine cells at early and late stages of gestation. Am J Path 1991, 139:327-335.
26. Hebisch G., Neumaier-Wagner P.M., Huch R., von Mandach U. Maternal serum interleukin-1β, -6 and -8 levels and potential determinants in pregnancy and peripartum. J Perinat Med 2004, 32:475-480.
27. Whitaker R.C. Predicting preschoolar obesity at birth: the role of maternal obesity in early pregnancy. Pediatrics 2004, 114:e29-e36.
28. Koupil I., Toiveanen P. Social and early-life determinants of overweight and obesity in 18-year-old Swedish men. Int J Obes 2008, 32:73-81.
29. Forsen T., Eriksson J.G., Tuomilehto J., Teramo K., Osmond C., Barker D.J. Mother's weight in pregnancy and coronary heart disease in a cohort of Finnish men: follow up study. Br Med J 1997, 315:837-840.
30. Radaelli T., Uvena-Celebrezze J., Minium J., Huston-Presley L., Catalano P., Hauguel-de Mouzon S. Maternal interleukin-6: marker of fetal growth and adiposity. Reprod Sci 2006, 13:53-57.
31. Fattah C., Farah N., O'Toole F., Barry S., Stuart B., Turner M.J. Body Mass Index (BMI) in women booking for antenatal care: comparison between selfreported and digital measurements. Eur J Obstet Gynecol Reprod Biol 2009, 144:32-34.
32. Hogan J.L., Farah N., O'Connor N., Kennelly M.M., Stuart B., Turner M.J. Bioelectrical impedance analysis and maternal body composition: reproducibility of bioelectrical impedance when analysing maternal body composition. Int J Body Compos Res 2011, 9:43-48.
33. Fattah C., Barry S., O'Connor N., Farah N., Stuart B., Turner M.J. Maternal leptin and body composition in the first trimester of pregnancy. J Gynecol Endocrin 2011, 27:263-266.
34. Turner M.J., Fattah C., Farah N., Stuart B. Body Mass Index and spontaneous miscarriage. Eur J Obstet Gynaecol Reprod Biol 2010, 151:169-170.